• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 的管理和治疗:中国经验。

Management and Treatment of COVID-19: The Chinese Experience.

机构信息

Center for Systems Medicine, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Suzhou Institute of Systems Medicine, Suzhou, Jiangsu, China.

Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Can J Cardiol. 2020 Jun;36(6):915-930. doi: 10.1016/j.cjca.2020.04.010. Epub 2020 Apr 17.

DOI:10.1016/j.cjca.2020.04.010
PMID:32439306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7162773/
Abstract

With more than 1,800,000 cases and 110,000 deaths globally, COVID-19 is one of worst infectious disease outbreaks in history. This paper provides a critical review of the available evidence regarding the lessons learned from the Chinese experience with COVID-19 prevention and management. The steps that have led to a near disappearance of new cases in China included rapid sequencing of the virus to establish testing kits, which allowed tracking of infected persons in and out of Wuhan. In addition, aggressive quarantine measures included the complete isolation of Wuhan and then later Hubei Province and the rest of the country, as well as closure of all schools and nonessential businesses. Other measures included the rapid construction of two new hospitals and the establishment of "Fangcang" shelter hospitals. In the absence of a vaccine, the management of COVID-19 included antivirals, high-flow oxygen, mechanical ventilation, corticosteroids, hydroxychloroquine, tocilizumab, interferons, intravenous immunoglobulin, and convalescent plasma infusions. These measures appeared to provide only moderate success. Although some measures have been supported by weak descriptive data, their effectiveness is still unclear pending well controlled clinical trials. In the end, it was the enforcement of drastic quarantine measures that stopped SARS-CoV-2 from spreading. The earlier the implementation, the less likely resources will be depleted. The most critical factors in stopping a pandemic are early recognition of infected individuals, carriers, and contacts and early implementation of quarantine measures with an organised, proactive, and unified strategy at a national level. Delays result in significantly higher death tolls.

摘要

全球有超过 180 万例病例和 11 万人死亡,COVID-19 是历史上最严重的传染病之一。本文对中国在 COVID-19 预防和管理方面的经验教训进行了批判性回顾。中国采取了一系列措施,使得境内新增病例近乎消失,这些措施包括:快速对病毒进行测序以建立检测试剂盒,从而可以追踪武汉及武汉以外的感染者;实施严格的隔离措施,包括对武汉、湖北省以及全国其他地区的全面隔离,以及关闭所有学校和非必要的商业场所;此外还包括迅速建设两所新医院和设立“方舱”收容医院。在没有疫苗的情况下,COVID-19 的治疗方法包括使用抗病毒药物、高流量吸氧、机械通气、皮质类固醇、羟氯喹、托珠单抗、干扰素、静脉注射免疫球蛋白和恢复期血浆输注。这些措施似乎只取得了中等程度的成功。虽然一些措施得到了弱描述性数据的支持,但在进行良好对照的临床试验之前,其有效性仍不清楚。最终,是严格的隔离措施阻止了 SARS-CoV-2 的传播。隔离措施实施得越早,资源耗尽的可能性就越小。阻止大流行的最关键因素是早期识别感染者、携带者和接触者,并在国家层面上采取有组织、积极主动和统一的策略来实施隔离措施。延迟会导致更高的死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac35/7162773/71ce71b44426/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac35/7162773/06c37ba0851f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac35/7162773/6e26d057f8ee/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac35/7162773/71ce71b44426/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac35/7162773/06c37ba0851f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac35/7162773/6e26d057f8ee/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac35/7162773/71ce71b44426/gr3_lrg.jpg

相似文献

1
Management and Treatment of COVID-19: The Chinese Experience.COVID-19 的管理和治疗:中国经验。
Can J Cardiol. 2020 Jun;36(6):915-930. doi: 10.1016/j.cjca.2020.04.010. Epub 2020 Apr 17.
2
The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.致命的冠状病毒:2003 年 SARS 大流行和 2020 年中国新型冠状病毒疫情。
J Autoimmun. 2020 May;109:102434. doi: 10.1016/j.jaut.2020.102434. Epub 2020 Mar 3.
3
Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.中国大陆(不含湖北省) 2019 年冠状病毒病(COVID-19)传播的风险估计和预测。
Infect Dis Poverty. 2020 Aug 24;9(1):116. doi: 10.1186/s40249-020-00683-6.
4
The Wuhan SARS-CoV-2-What's next for China.武汉的新冠病毒——中国的下一步是什么。
J Med Virol. 2020 Jun;92(6):546-547. doi: 10.1002/jmv.25738. Epub 2020 Mar 18.
5
[The outbreak of COVID-19 in China].[中国新冠疫情的爆发]
Internist (Berl). 2020 Aug;61(8):776-781. doi: 10.1007/s00108-020-00833-w.
6
The effectiveness of quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): A well-mixed SEIR model analysis.武汉市对 2019 年冠状病毒病(COVID-19)的隔离措施的有效性:一个混合 SEIR 模型分析。
J Med Virol. 2020 Jul;92(7):841-848. doi: 10.1002/jmv.25827. Epub 2020 Apr 25.
7
How Shenzhen, China avoided widespread community transmission: a potential model for successful prevention and control of COVID-19.中国深圳如何避免社区广泛传播:COVID-19 成功预防和控制的潜在模式。
Infect Dis Poverty. 2020 Jul 10;9(1):89. doi: 10.1186/s40249-020-00714-2.
8
Preparedness and Preventive Behaviors for a Pandemic Disaster Caused by COVID-19 in Serbia.塞尔维亚应对 COVID-19 大流行灾害的准备和预防行为。
Int J Environ Res Public Health. 2020 Jun 9;17(11):4124. doi: 10.3390/ijerph17114124.
9
Where are we with understanding of COVID-19?我们对新冠病毒的了解处于什么程度?
Adv Biol Regul. 2020 Aug;77:100745. doi: 10.1016/j.jbior.2020.100745. Epub 2020 Jul 21.
10
Weathering COVID-19 storm: Successful control measures of five Asian countries.应对新冠疫情风暴:五个亚洲国家成功的防控措施。
Am J Infect Control. 2020 Jul;48(7):851-852. doi: 10.1016/j.ajic.2020.04.021. Epub 2020 Apr 29.

引用本文的文献

1
Comparison of the ALKA and CRS scores to predict outcomes among patients with coronavirus disease 2019 infection in United Arab Emirates.比较ALKA和CRS评分以预测阿拉伯联合酋长国2019冠状病毒病感染患者的预后。
Front Med (Lausanne). 2025 Aug 18;12:1553189. doi: 10.3389/fmed.2025.1553189. eCollection 2025.
2
Analysis of HFE impact of COVID-19 on OHS in construction enterprises.新冠疫情对建筑企业职业健康安全(OHS)的HFE影响分析
Heliyon. 2024 Dec 16;11(1):e41275. doi: 10.1016/j.heliyon.2024.e41275. eCollection 2025 Jan 15.
3
Innovative public strategies in response to COVID-19: A review of practices from China.

本文引用的文献

1
A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases - Wuhan, China 2019-2020.在中国武汉2019 - 2020年肺炎病例群中发现的一种新型冠状病毒基因组
China CDC Wkly. 2020 Jan 24;2(4):61-62.
2
Daily briefing: First coronavirus vaccine clinical trials begin in United States.每日简报:美国开始首例新冠病毒疫苗临床试验。
Nature. 2020 Mar 17. doi: 10.1038/d41586-020-00802-1.
3
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?穿山甲是否是 2019 新型冠状病毒(SARS-CoV-2)的中间宿主?
应对新冠疫情的创新性公共策略:来自中国的实践综述
Health Care Sci. 2024 Dec 18;3(6):383-408. doi: 10.1002/hcs2.122. eCollection 2024 Dec.
4
The impact of COVID-19 on referrals among general practitioners and specialists in Shanghai, China.新冠疫情对中国上海全科医生和专科医生转诊的影响。
Prim Health Care Res Dev. 2024 Nov 20;25:e63. doi: 10.1017/S1463423624000525.
5
Spatiotemporal patterns and socioeconomic determinants of pulmonary tuberculosis in Dongguan city, China, during 2011-2020: an ecological study.2011-2020 年中国东莞市肺结核时空分布特征及社会经济决定因素的生态学研究。
BMJ Open. 2024 Sep 10;14(9):e085733. doi: 10.1136/bmjopen-2024-085733.
6
Gap in protective behaviors between Han and minority ethnicities during COVID-19 pandemic in rural western China: A decomposition analysis.中国西部农村地区新冠疫情期间汉族与少数民族防护行为的差距:分解分析
Prev Med Rep. 2024 Jan 28;39:102617. doi: 10.1016/j.pmedr.2024.102617. eCollection 2024 Mar.
7
How calling emerges and develops during COVID-19: a qualitative study of medical students.在 COVID-19 期间呼唤的出现和发展:对医学生的定性研究。
BMC Med Educ. 2023 Dec 8;23(1):929. doi: 10.1186/s12909-023-04914-w.
8
Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity.长链非编码 RNA ANRIL、THRIL 和 NEAT1 作为 SARS-CoV-2 感染和疾病严重程度的潜在循环生物标志物。
Virus Res. 2023 Oct 15;336:199214. doi: 10.1016/j.virusres.2023.199214. Epub 2023 Sep 11.
9
Systemic Review and Meta-Analysis to Evaluate Therapeutic Effectiveness of Interferon Beta-1b in Hospitalized COVID-19 Patients.评估β-1b干扰素对住院COVID-19患者治疗效果的系统评价和荟萃分析
Indian J Community Med. 2023 May-Jun;48(3):390-400. doi: 10.4103/ijcm.ijcm_577_22. Epub 2023 May 30.
10
Biogenesis, Composition and Potential Therapeutic Applications of Mesenchymal Stem Cells Derived Exosomes in Various Diseases.间充质干细胞衍生外泌体的发生、组成及在各种疾病中的潜在治疗应用。
Int J Nanomedicine. 2023 Jun 14;18:3177-3210. doi: 10.2147/IJN.S407029. eCollection 2023.
PLoS Pathog. 2020 May 14;16(5):e1008421. doi: 10.1371/journal.ppat.1008421. eCollection 2020 May.
4
[Diagnosis and treatment recommendation for pediatric COVID-19 (the second edition)].儿童新型冠状病毒肺炎诊疗建议(第二版)
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):139-146. doi: 10.3785/j.issn.1008-9292.2020.02.01.
5
[Chinese experts' consensus on diagnosis and treatment of severe and critical coronavirus disease 2019 (revised edition)].《新型冠状病毒肺炎重型、危重型病例诊疗中国专家共识(修订版)》
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Mar;32(3):269-274. doi: 10.3760/cma.j.cn121430-20200218-00188.
6
Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China.中国武汉 323 例新型冠状病毒病(COVID-19)住院患者临床结局的相关危险因素分析。
Clin Infect Dis. 2020 Nov 19;71(16):2089-2098. doi: 10.1093/cid/ciaa539.
7
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.使用临床级别的可溶性人血管紧张素转化酶 2 抑制工程化人类组织中的 SARS-CoV-2 感染。
Cell. 2020 May 14;181(4):905-913.e7. doi: 10.1016/j.cell.2020.04.004. Epub 2020 Apr 24.
8
Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.精准皮质类固醇治疗对重症2019新型冠状病毒肺炎的潜在益处。
Signal Transduct Target Ther. 2020 Feb 21;5(1):18. doi: 10.1038/s41392-020-0127-9.
9
Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection.新型冠状病毒肺炎感染潜伏期接受手术患者的临床特征及预后
EClinicalMedicine. 2020 Apr 5;21:100331. doi: 10.1016/j.eclinm.2020.100331. eCollection 2020 Apr.
10
Holistic care for patients with severe coronavirus disease 2019: An expert consensus.2019年冠状病毒病重症患者的整体护理:专家共识
Int J Nurs Sci. 2020 Apr 4;7(2):128-134. doi: 10.1016/j.ijnss.2020.03.010. eCollection 2020 Apr 10.